Treatment of Dyslipidemia in Common Liver Diseases.
作者信息
Speliotes Elizabeth K, Balakrishnan Maya, Friedman Lawrence S, Corey Kathleen E
机构信息
Department of Internal Medicine, Division of Gastroenterology and Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.
Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine, Houston, Texas.
出版信息
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1189-1196. doi: 10.1016/j.cgh.2018.04.023. Epub 2018 Apr 21.
Abstract
摘要
相似文献
1
Treatment of Dyslipidemia in Common Liver Diseases.常见肝脏疾病中的血脂异常治疗
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1189-1196. doi: 10.1016/j.cgh.2018.04.023. Epub 2018 Apr 21.
2
[Hepatic changes in patients with atherogenic dyslipidemia].[动脉粥样硬化性血脂异常患者的肝脏变化]
Eksp Klin Gastroenterol. 2008(5):111-9.
3
[Dyslipidemia].[血脂异常]
Rev Prat. 2011 Jan;61(1):93-102.
4
[Detection, evaluation, target and clinical significance of dyslipidemia management].血脂异常管理的检测、评估、目标及临床意义
Nihon Rinsho. 2007 Jul 28;65 Suppl 7:429-34.
5
[How to apply clinical guidelines in medical practice? The example of dyslipidemia].[如何在医疗实践中应用临床指南？以血脂异常为例]
Rev Med Suisse. 2008 Mar 12;4(148):662-5.
6
[Management of dyslipidemia in the elderly].[老年人血脂异常的管理]
Nihon Ronen Igakkai Zasshi. 2013;50(5):619-21. doi: 10.3143/geriatrics.50.619.
7
Missed targets: gender differences in the identification and management of dyslipidemia.未达目标：血脂异常识别与管理中的性别差异
J Cardiovasc Nurs. 2006 Sep-Oct;21(5):342-6. doi: 10.1097/00005082-200609000-00003.
8
Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.糖尿病血脂异常综述：糖尿病血脂异常的当前概念与管理指南更新
Am J Med Sci. 2016 Apr;351(4):361-5. doi: 10.1016/j.amjms.2016.01.020. Epub 2016 Feb 2.
9
[How to deal with familial dyslipidemia in clinical practice?].[临床实践中如何处理家族性血脂异常？]
Rev Med Suisse. 2012 Mar 7;8(331):494-6, 498-500.
10
The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?近期国家脂质协会的建议：与其他已确立的血脂异常指南相比情况如何？
Curr Atheroscler Rep. 2015 Apr;17(4):494. doi: 10.1007/s11883-015-0494-9.
引用本文的文献
1
Low-density lipoprotein cholesterol and clinical outcomes in patients with liver cirrhosis: a nationwide cohort study.肝硬化患者的低密度脂蛋白胆固醇与临床结局：一项全国性队列研究。
Ann Med. 2025 Dec;57(1):2551813. doi: 10.1080/07853890.2025.2551813. Epub 2025 Aug 30.
2
Co-Supplementation of Policosanol and Banaba Leaf Extract Exhibited a Cooperative Effect Against Hyperglycemia and Dyslipidemia in Zebrafish: Highlighting Vital Organ Protection Against High-Cholesterol and High-Galactose Diet.聚二十碳五烯醇与巴拿巴叶提取物联合补充对斑马鱼高血糖和血脂异常具有协同作用：突出对高胆固醇和高半乳糖饮食下重要器官的保护作用。
Int J Mol Sci. 2025 Aug 8;26(16):7669. doi: 10.3390/ijms26167669.
3
Impact of statins in the liver: A bane or a boon?他汀类药物对肝脏的影响：是祸还是福？
Can Liver J. 2024 Mar 13;7(4):490-499. doi: 10.3138/canlivj-2023-0028. eCollection 2024 Dec.
4
Synergistic Effect of Banaba Leaf Extract and Policosanol (Raydel) Ameliorate High Cholesterol and High Galactose-Diet Induced Adverse Events in Zebrafish.巴拿巴叶提取物与 policosanol（雷代尔）的协同作用改善高胆固醇和高糖饮食诱导的斑马鱼不良事件。
Pharmaceuticals (Basel). 2025 Jun 9;18(6):860. doi: 10.3390/ph18060860.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review.代谢功能障碍相关脂肪性肝病（MASLD）：最新综述
J Obes Metab Syndr. 2023 Sep 30;32(3):197-213. doi: 10.7570/jomes23052. Epub 2023 Sep 13.
6
Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.晚期失代偿性肝硬化的表现极为常见，但成功的病因治疗可带来良好的临床结果。
PLoS One. 2023 Aug 24;18(8):e0290352. doi: 10.1371/journal.pone.0290352. eCollection 2023.
7
Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.慢性肝脏疾病患者脑卒中的管理：实用综述。
Stroke. 2023 Sep;54(9):2461-2471. doi: 10.1161/STROKEAHA.123.043011. Epub 2023 Jul 7.
8
Chronic liver disease is not associated with statin prescription in a primary care cohort.慢性肝病与初级保健队列中的他汀类药物处方无关。
J Investig Med. 2023 Dec;71(8):830-837. doi: 10.1177/10815589231185356. Epub 2023 Jul 3.
9
Protection of Liver Functions and Improvement of Kidney Functions by Twelve Weeks Consumption of Cuban Policosanol (Raydel) with a Decrease of Glycated Hemoglobin and Blood Pressure from a Randomized, Placebo-Controlled, and Double-Blinded Study with Healthy and Middle-Aged Japanese Participants.一项针对健康中年日本参与者的随机、安慰剂对照、双盲研究表明，连续十二周服用古巴聚戊烯醇（Raydel）可保护肝功能、改善肾功能，并降低糖化血红蛋白和血压。
Life (Basel). 2023 Jun 4;13(6):1319. doi: 10.3390/life13061319.
10
Cytarabine induces cachexia with lipid malabsorption via zippering the junctions of lacteal in murine small intestine.阿糖胞苷通过拉链连接乳糜管在鼠小肠中的连接诱导恶病质伴脂肪吸收不良。
J Lipid Res. 2023 Jun;64(6):100387. doi: 10.1016/j.jlr.2023.100387. Epub 2023 May 16.
本文引用的文献
1
Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.他汀类药物的使用与慢性肝病患者肝硬化及相关并发症风险的关系：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1521-1530.e8. doi: 10.1016/j.cgh.2017.04.039. Epub 2017 May 4.
2
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.EASL 临床实践指南：原发性胆汁性胆管炎患者的诊断和管理。
J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.
3
Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.他汀类药物降低乙型肝炎病毒和丙型肝炎病毒相关肝硬化失代偿的风险：一项基于人群的研究。
Hepatology. 2017 Sep;66(3):896-907. doi: 10.1002/hep.29172. Epub 2017 May 8.
4
Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis.依折麦布治疗非酒精性脂肪性肝病的荟萃分析。
Hepatol Res. 2017 Dec;47(13):1417-1428. doi: 10.1111/hepr.12887. Epub 2017 Apr 1.
5
[Obeticholic acid in primary biliary cholangitis : PBC OCA international study of efficacy (POISE)].[奥贝胆酸治疗原发性胆汁性胆管炎：PBC OCA国际疗效研究（POISE）]
Internist (Berl). 2017 Feb;58(2):202-204. doi: 10.1007/s00108-016-0185-9.
6
Fibrates for primary prevention of cardiovascular disease events.贝特类药物用于心血管疾病事件的一级预防。
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009753. doi: 10.1002/14651858.CD009753.pub2.
7
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.他汀类药物与丙型肝炎相关代偿期肝硬化退伍军人失代偿和死亡风险降低相关。
Gastroenterology. 2016 Feb;150(2):430-40.e1. doi: 10.1053/j.gastro.2015.10.007. Epub 2015 Oct 17.
8
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial).依泽替米贝治疗非酒精性脂肪性肝炎：一项随机试验（莫扎特试验）中采用新型磁共振成像和磁共振弹性成像的评估
Hepatology. 2015 Apr;61(4):1239-50. doi: 10.1002/hep.27647. Epub 2015 Feb 27.
9
An assessment by the Statin Liver Safety Task Force: 2014 update.他汀类药物肝安全性工作组评估：2014 年更新。
J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S47-57. doi: 10.1016/j.jacl.2014.02.011.
10
Statins and liver injury.他汀类药物与肝损伤。
Gastroenterol Hepatol (N Y). 2013 Sep;9(9):605-6.
Zotero 插件